Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander
Diabetes mellitus incrementa el riesgo de amputación en miembros inferiores. Se han estudiado diferentes factores de riesgo con el objetivo de establecer asociación con la amputación en pacientes con pie diabético. 2,3,4,5,6,7. El objetivo fue determinar cuáles factores de riesgo se encontraban asoc...
- Autores:
-
Cepeda Jordan, Ricardo
- Tipo de recurso:
- http://purl.org/coar/version/c_b1a7d7d4d402bcce
- Fecha de publicación:
- 2016
- Institución:
- Universidad Industrial de Santander
- Repositorio:
- Repositorio UIS
- Idioma:
- spa
- OAI Identifier:
- oai:noesis.uis.edu.co:20.500.14071/35368
- Palabra clave:
- Pie Diabético
Amputación
Wagner
Hemoglobina
Glicosilado Description:
Introduction. Diabetes mellitus increases the risk of amputation in lower limbs. We have studied different risk factors with the aim of establishing partnership with amputation in patients with diabetic foot. 2
3
4
5
6
7. the objective was to determine which risk factors associated met with amputation in patients with diabetic foot. Hypothesis: patients with hemoglobin-glycosylated > 8% and > 65 years had an increased risk of amputation. Materials and methods. Analytical
observational
cross-sectional study. 72 patients with a diagnosis of diabetic foot supported by emergency room of the University Hospital of Santander 2013 to 2015
follow-up for 6 months. Results. The prevalence of amputation between 2013 to 2015 was 72% with 52 cases
amputation higher (67%) 35 cases
amputation lowest (33%) 17 cases. Amputation in patients > 65 years was associated with the female gender OR 5 CI (1-25) q: 0.039
glycosylatedem hoglobin > 10% OR: 1.6 (1
3-2
1) IC and Wagner v
OR 1.7 IC (1
3-2
2)
with peripheral arterial disease Occlusive OR:4 IC (1
1-14). LLA amputation in patients < 65 years was associated with levels of glycosylated hemoglobin < 6% OR 6.4 CI (1
5-26). levels of glycosylated hemoglobin < 6% were constituted in a protective factor for amputation patients < 65 years OR more: 0.1 IC (0
02-0
4). the proportion of mortality in the Group of amputees was 25% and in the Group of non-amputated 10%. conclusions. Amputation associated with age > 65 years
female gender
glycosylated hemoglobin > 10%
Wagner V
and peripheral arterial Occlusive Disease. Patients come late to the health system with complications of difficult management and advanced stages and glycosylated hemoglobin levels > 10%. These aspects influence survival. Key words: diabetes
complications
diabetic foot and its complications
management
treatment
amputation
- Rights
- License
- Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
id |
UISANTADR2_ae15ae1152243f355428012bca71f14a |
---|---|
oai_identifier_str |
oai:noesis.uis.edu.co:20.500.14071/35368 |
network_acronym_str |
UISANTADR2 |
network_name_str |
Repositorio UIS |
repository_id_str |
|
dc.title.none.fl_str_mv |
Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander |
dc.title.english.none.fl_str_mv |
Diabetes Foot, Amputation, Wagner, Hemoglobin, Glycated |
title |
Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander |
spellingShingle |
Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander Pie Diabético Amputación Wagner Hemoglobina Glicosilado Description: Introduction. Diabetes mellitus increases the risk of amputation in lower limbs. We have studied different risk factors with the aim of establishing partnership with amputation in patients with diabetic foot. 2 3 4 5 6 7. the objective was to determine which risk factors associated met with amputation in patients with diabetic foot. Hypothesis: patients with hemoglobin-glycosylated > 8% and > 65 years had an increased risk of amputation. Materials and methods. Analytical observational cross-sectional study. 72 patients with a diagnosis of diabetic foot supported by emergency room of the University Hospital of Santander 2013 to 2015 follow-up for 6 months. Results. The prevalence of amputation between 2013 to 2015 was 72% with 52 cases amputation higher (67%) 35 cases amputation lowest (33%) 17 cases. Amputation in patients > 65 years was associated with the female gender OR 5 CI (1-25) q: 0.039 glycosylatedem hoglobin > 10% OR: 1.6 (1 3-2 1) IC and Wagner v OR 1.7 IC (1 3-2 2) with peripheral arterial disease Occlusive OR:4 IC (1 1-14). LLA amputation in patients < 65 years was associated with levels of glycosylated hemoglobin < 6% OR 6.4 CI (1 5-26). levels of glycosylated hemoglobin < 6% were constituted in a protective factor for amputation patients < 65 years OR more: 0.1 IC (0 02-0 4). the proportion of mortality in the Group of amputees was 25% and in the Group of non-amputated 10%. conclusions. Amputation associated with age > 65 years female gender glycosylated hemoglobin > 10% Wagner V and peripheral arterial Occlusive Disease. Patients come late to the health system with complications of difficult management and advanced stages and glycosylated hemoglobin levels > 10%. These aspects influence survival. Key words: diabetes complications diabetic foot and its complications management treatment amputation |
title_short |
Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander |
title_full |
Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander |
title_fullStr |
Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander |
title_full_unstemmed |
Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander |
title_sort |
Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander |
dc.creator.fl_str_mv |
Cepeda Jordan, Ricardo |
dc.contributor.advisor.none.fl_str_mv |
Reyes Nuñez, Victor Arturo |
dc.contributor.author.none.fl_str_mv |
Cepeda Jordan, Ricardo |
dc.subject.none.fl_str_mv |
Pie Diabético Amputación Wagner Hemoglobina Glicosilado Description: |
topic |
Pie Diabético Amputación Wagner Hemoglobina Glicosilado Description: Introduction. Diabetes mellitus increases the risk of amputation in lower limbs. We have studied different risk factors with the aim of establishing partnership with amputation in patients with diabetic foot. 2 3 4 5 6 7. the objective was to determine which risk factors associated met with amputation in patients with diabetic foot. Hypothesis: patients with hemoglobin-glycosylated > 8% and > 65 years had an increased risk of amputation. Materials and methods. Analytical observational cross-sectional study. 72 patients with a diagnosis of diabetic foot supported by emergency room of the University Hospital of Santander 2013 to 2015 follow-up for 6 months. Results. The prevalence of amputation between 2013 to 2015 was 72% with 52 cases amputation higher (67%) 35 cases amputation lowest (33%) 17 cases. Amputation in patients > 65 years was associated with the female gender OR 5 CI (1-25) q: 0.039 glycosylatedem hoglobin > 10% OR: 1.6 (1 3-2 1) IC and Wagner v OR 1.7 IC (1 3-2 2) with peripheral arterial disease Occlusive OR:4 IC (1 1-14). LLA amputation in patients < 65 years was associated with levels of glycosylated hemoglobin < 6% OR 6.4 CI (1 5-26). levels of glycosylated hemoglobin < 6% were constituted in a protective factor for amputation patients < 65 years OR more: 0.1 IC (0 02-0 4). the proportion of mortality in the Group of amputees was 25% and in the Group of non-amputated 10%. conclusions. Amputation associated with age > 65 years female gender glycosylated hemoglobin > 10% Wagner V and peripheral arterial Occlusive Disease. Patients come late to the health system with complications of difficult management and advanced stages and glycosylated hemoglobin levels > 10%. These aspects influence survival. Key words: diabetes complications diabetic foot and its complications management treatment amputation |
dc.subject.keyword.none.fl_str_mv |
Introduction. Diabetes mellitus increases the risk of amputation in lower limbs. We have studied different risk factors with the aim of establishing partnership with amputation in patients with diabetic foot. 2 3 4 5 6 7. the objective was to determine which risk factors associated met with amputation in patients with diabetic foot. Hypothesis: patients with hemoglobin-glycosylated > 8% and > 65 years had an increased risk of amputation. Materials and methods. Analytical observational cross-sectional study. 72 patients with a diagnosis of diabetic foot supported by emergency room of the University Hospital of Santander 2013 to 2015 follow-up for 6 months. Results. The prevalence of amputation between 2013 to 2015 was 72% with 52 cases amputation higher (67%) 35 cases amputation lowest (33%) 17 cases. Amputation in patients > 65 years was associated with the female gender OR 5 CI (1-25) q: 0.039 glycosylatedem hoglobin > 10% OR: 1.6 (1 3-2 1) IC and Wagner v OR 1.7 IC (1 3-2 2) with peripheral arterial disease Occlusive OR:4 IC (1 1-14). LLA amputation in patients < 65 years was associated with levels of glycosylated hemoglobin < 6% OR 6.4 CI (1 5-26). levels of glycosylated hemoglobin < 6% were constituted in a protective factor for amputation patients < 65 years OR more: 0.1 IC (0 02-0 4). the proportion of mortality in the Group of amputees was 25% and in the Group of non-amputated 10%. conclusions. Amputation associated with age > 65 years female gender glycosylated hemoglobin > 10% Wagner V and peripheral arterial Occlusive Disease. Patients come late to the health system with complications of difficult management and advanced stages and glycosylated hemoglobin levels > 10%. These aspects influence survival. Key words: diabetes complications diabetic foot and its complications management treatment amputation |
description |
Diabetes mellitus incrementa el riesgo de amputación en miembros inferiores. Se han estudiado diferentes factores de riesgo con el objetivo de establecer asociación con la amputación en pacientes con pie diabético. 2,3,4,5,6,7. El objetivo fue determinar cuáles factores de riesgo se encontraban asociados con la amputación en pacientes con pie diabético. Hipótesis: pacientes con hemoglobina glicosilada > 8% y > 65 años tenían un mayor riesgo de amputación. Materiales y métodos. Estudio analítico, observacional, corte transversal. 72 pacientes con diagnóstico de pie diabético admitidos por urgencias del Hospital Universitario de Santander 2013 a 2015,seguimiento por 6 meses . Resultados. La prevalencia de amputación 2013 a 2015 fue de 72% con 52 casos, amputación mayor (67%) 35 casos, amputación menor (33%) 17 casos. La amputación mayor en pacientes > 65 años estuvo asociada con el género femenino OR 5 IC (1-25) p: 0,039, hemoglobina glicosilada > 10% OR: 1,6 IC (1,3-2,1) y a Wagner V, OR 1,7 IC (1,3-2,2), con enfermedad arterial periférica oclusiva OR:4 IC (1,1-14). Lla amputación menor en pacientes < 65 años estuvo asociada a niveles de hemoglobina glicosilada < 6% OR 6,4 IC (1,5-26). Los niveles de hemoglobina glicosilada < 6% se constituyeron en un factor protector para la amputación mayor en pacientes < 65 años OR: 0,1 IC (0,02-0,4). La proporción de mortalidad en el grupo de amputados fue 25% y en el grupo de no amputados 10%. Conclusiones. La amputación se asoció a edad > 65 años, género femenino, hemoglobina glicosilada >10%, Wagner V, y enfermedad arterial periférica oclusiva. Los pacientes acuden de manera tardía al sistema sanitario con complicaciones de difícil manejo y estadios avanzados y niveles de hemoglobina glicosilada > 10%. Estos aspectos influyen en la supervivencia . Palabras clave: diabetes, complicaciones, pie diabético y sus complicaciones, manejo, tratamiento, amputación |
publishDate |
2016 |
dc.date.available.none.fl_str_mv |
2016 2024-03-03T22:48:17Z |
dc.date.created.none.fl_str_mv |
2016 |
dc.date.issued.none.fl_str_mv |
2016 |
dc.date.accessioned.none.fl_str_mv |
2024-03-03T22:48:17Z |
dc.type.local.none.fl_str_mv |
Tesis/Trabajo de grado - Monografía - Pregrado |
dc.type.hasversion.none.fl_str_mv |
http://purl.org/coar/resource_type/c_7a1f |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/version/c_b1a7d7d4d402bcce |
format |
http://purl.org/coar/version/c_b1a7d7d4d402bcce |
dc.identifier.uri.none.fl_str_mv |
https://noesis.uis.edu.co/handle/20.500.14071/35368 |
dc.identifier.instname.none.fl_str_mv |
Universidad Industrial de Santander |
dc.identifier.reponame.none.fl_str_mv |
Universidad Industrial de Santander |
dc.identifier.repourl.none.fl_str_mv |
https://noesis.uis.edu.co |
url |
https://noesis.uis.edu.co/handle/20.500.14071/35368 https://noesis.uis.edu.co |
identifier_str_mv |
Universidad Industrial de Santander |
dc.language.iso.none.fl_str_mv |
spa |
language |
spa |
dc.rights.none.fl_str_mv |
http://creativecommons.org/licenses/by/4.0/ |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.license.none.fl_str_mv |
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) |
dc.rights.uri.none.fl_str_mv |
http://creativecommons.org/licenses/by-nc/4.0 |
dc.rights.creativecommons.none.fl_str_mv |
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) |
rights_invalid_str_mv |
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by-nc/4.0 Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidad Industrial de Santander |
dc.publisher.faculty.none.fl_str_mv |
Facultad de Salud |
dc.publisher.program.none.fl_str_mv |
Especialización en Ortopedia y Traumatología |
dc.publisher.school.none.fl_str_mv |
Escuela de Medicina |
publisher.none.fl_str_mv |
Universidad Industrial de Santander |
institution |
Universidad Industrial de Santander |
bitstream.url.fl_str_mv |
https://noesis.uis.edu.co/bitstreams/e0cae3a1-7a86-4ad3-b75d-c26ba9fae33a/download https://noesis.uis.edu.co/bitstreams/38f386c6-b6aa-4d4a-9b1e-0a640804f655/download https://noesis.uis.edu.co/bitstreams/42b95551-f55f-4891-81d0-41505b510f10/download |
bitstream.checksum.fl_str_mv |
f0796fd4707cf94f6807ee1c4c03300d 65b16e1c9f4e7a16aeb4277cc657612c 5e7201c300a198980b4c9ba15bae2e6d |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
DSpace at UIS |
repository.mail.fl_str_mv |
noesis@uis.edu.co |
_version_ |
1814095170983952384 |
spelling |
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)http://creativecommons.org/licenses/by/4.0/http://creativecommons.org/licenses/by-nc/4.0Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)http://purl.org/coar/access_right/c_abf2Reyes Nuñez, Victor ArturoCepeda Jordan, Ricardo2024-03-03T22:48:17Z20162024-03-03T22:48:17Z20162016https://noesis.uis.edu.co/handle/20.500.14071/35368Universidad Industrial de SantanderUniversidad Industrial de Santanderhttps://noesis.uis.edu.coDiabetes mellitus incrementa el riesgo de amputación en miembros inferiores. Se han estudiado diferentes factores de riesgo con el objetivo de establecer asociación con la amputación en pacientes con pie diabético. 2,3,4,5,6,7. El objetivo fue determinar cuáles factores de riesgo se encontraban asociados con la amputación en pacientes con pie diabético. Hipótesis: pacientes con hemoglobina glicosilada > 8% y > 65 años tenían un mayor riesgo de amputación. Materiales y métodos. Estudio analítico, observacional, corte transversal. 72 pacientes con diagnóstico de pie diabético admitidos por urgencias del Hospital Universitario de Santander 2013 a 2015,seguimiento por 6 meses . Resultados. La prevalencia de amputación 2013 a 2015 fue de 72% con 52 casos, amputación mayor (67%) 35 casos, amputación menor (33%) 17 casos. La amputación mayor en pacientes > 65 años estuvo asociada con el género femenino OR 5 IC (1-25) p: 0,039, hemoglobina glicosilada > 10% OR: 1,6 IC (1,3-2,1) y a Wagner V, OR 1,7 IC (1,3-2,2), con enfermedad arterial periférica oclusiva OR:4 IC (1,1-14). Lla amputación menor en pacientes < 65 años estuvo asociada a niveles de hemoglobina glicosilada < 6% OR 6,4 IC (1,5-26). Los niveles de hemoglobina glicosilada < 6% se constituyeron en un factor protector para la amputación mayor en pacientes < 65 años OR: 0,1 IC (0,02-0,4). La proporción de mortalidad en el grupo de amputados fue 25% y en el grupo de no amputados 10%. Conclusiones. La amputación se asoció a edad > 65 años, género femenino, hemoglobina glicosilada >10%, Wagner V, y enfermedad arterial periférica oclusiva. Los pacientes acuden de manera tardía al sistema sanitario con complicaciones de difícil manejo y estadios avanzados y niveles de hemoglobina glicosilada > 10%. Estos aspectos influyen en la supervivencia . Palabras clave: diabetes, complicaciones, pie diabético y sus complicaciones, manejo, tratamiento, amputaciónEspecializaciónEspecialista en Ortopedia y TraumatologíaRisk factors associated with amputation in patients with diabetic foot in santander university hospitalapplication/pdfspaUniversidad Industrial de SantanderFacultad de SaludEspecialización en Ortopedia y TraumatologíaEscuela de MedicinaPie DiabéticoAmputaciónWagnerHemoglobinaGlicosilado Description:Introduction. Diabetes mellitus increases the risk of amputation in lower limbs. We have studied different risk factors with the aim of establishing partnership with amputation in patients with diabetic foot. 234567. the objective was to determine which risk factors associated met with amputation in patients with diabetic foot. Hypothesis: patients with hemoglobin-glycosylated > 8% and > 65 years had an increased risk of amputation. Materials and methods. Analyticalobservationalcross-sectional study. 72 patients with a diagnosis of diabetic foot supported by emergency room of the University Hospital of Santander 2013 to 2015follow-up for 6 months. Results. The prevalence of amputation between 2013 to 2015 was 72% with 52 casesamputation higher (67%) 35 casesamputation lowest (33%) 17 cases. Amputation in patients > 65 years was associated with the female gender OR 5 CI (1-25) q: 0.039glycosylatedem hoglobin > 10% OR: 1.6 (13-21) IC and Wagner vOR 1.7 IC (13-22)with peripheral arterial disease Occlusive OR:4 IC (11-14). LLA amputation in patients < 65 years was associated with levels of glycosylated hemoglobin < 6% OR 6.4 CI (15-26). levels of glycosylated hemoglobin < 6% were constituted in a protective factor for amputation patients < 65 years OR more: 0.1 IC (002-04). the proportion of mortality in the Group of amputees was 25% and in the Group of non-amputated 10%. conclusions. Amputation associated with age > 65 yearsfemale genderglycosylated hemoglobin > 10%Wagner Vand peripheral arterial Occlusive Disease. Patients come late to the health system with complications of difficult management and advanced stages and glycosylated hemoglobin levels > 10%. These aspects influence survival. Key words: diabetescomplicationsdiabetic foot and its complicationsmanagementtreatmentamputationFactores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de SantanderDiabetes Foot, Amputation, Wagner, Hemoglobin, GlycatedTesis/Trabajo de grado - Monografía - Pregradohttp://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/version/c_b1a7d7d4d402bcceORIGINALCarta de autorización.pdfapplication/pdf143834https://noesis.uis.edu.co/bitstreams/e0cae3a1-7a86-4ad3-b75d-c26ba9fae33a/downloadf0796fd4707cf94f6807ee1c4c03300dMD51Documento.pdfapplication/pdf1590114https://noesis.uis.edu.co/bitstreams/38f386c6-b6aa-4d4a-9b1e-0a640804f655/download65b16e1c9f4e7a16aeb4277cc657612cMD52Nota de proyecto.pdfapplication/pdf154655https://noesis.uis.edu.co/bitstreams/42b95551-f55f-4891-81d0-41505b510f10/download5e7201c300a198980b4c9ba15bae2e6dMD5320.500.14071/35368oai:noesis.uis.edu.co:20.500.14071/353682024-03-03 17:48:17.923http://creativecommons.org/licenses/by-nc/4.0http://creativecommons.org/licenses/by/4.0/open.accesshttps://noesis.uis.edu.coDSpace at UISnoesis@uis.edu.co |